You are viewing a single comment's thread from:RE: Proteostasis Therapeutics Inc (PTI)View the full contextvato (56)in #stocks • 8 years ago The year-to-date performance of the stock is 88.25%. The monthly stock performance comes in at 34.26%. For the quarter, shares are performing at 104.42%. Based on the current consensus analyst target Price of 15.75, analysts have a current recommendation of 1.80 on the shares. This is on a consensus basis according to Thomson Reuters.